Cargando…

Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania

BACKGROUND: Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the us...

Descripción completa

Detalles Bibliográficos
Autores principales: Djigo, Oum kelthoum Mamadou, Bollahi, Mohamed Abdallahi, Hasni Ebou, Moina, Ould Ahmedou Salem, Mohamed Salem, Tahar, Rachida, Bogreau, Hervé, Basco, Leonardo, Ould Mohamed Salem Boukhary, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746352/
https://www.ncbi.nlm.nih.gov/pubmed/31525211
http://dx.doi.org/10.1371/journal.pone.0220977
_version_ 1783451691563089920
author Djigo, Oum kelthoum Mamadou
Bollahi, Mohamed Abdallahi
Hasni Ebou, Moina
Ould Ahmedou Salem, Mohamed Salem
Tahar, Rachida
Bogreau, Hervé
Basco, Leonardo
Ould Mohamed Salem Boukhary, Ali
author_facet Djigo, Oum kelthoum Mamadou
Bollahi, Mohamed Abdallahi
Hasni Ebou, Moina
Ould Ahmedou Salem, Mohamed Salem
Tahar, Rachida
Bogreau, Hervé
Basco, Leonardo
Ould Mohamed Salem Boukhary, Ali
author_sort Djigo, Oum kelthoum Mamadou
collection PubMed
description BACKGROUND: Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the use of primaquine has been limited in Africa. In the present study, G6PD deficiency was investigated in blood donors of various ethnic groups living in Nouakchott, a P. vivax endemic area in Mauritania. METHODOLOGY/PRINCIPAL FINDINGS: Venous blood samples from 443 healthy blood donors recruited at the National Transfusion Center in Nouakchott were screened for G6PD activity using the CareStart G6PD deficiency rapid diagnostic test. G6PD allelic variants were investigated using DiaPlexC G6PD genotyping kit that detects African (A(-)) and Mediterranean (B(-)) variants. Overall, 50 of 443 (11.3%) individuals (49 [11.8%] men and 1 [3.7%] woman) were phenotypically deficient. Amongst men, Black Africans had the highest prevalence of G6PD deficiency (15 of 100 [15%]) and White Moors the lowest (10 of 168, [5.9%]). The most commonly observed G6PD allelic variants among 44 tested G6PD-deficient men were the African variant A(-) (202A/376G) in 14 (31.8%), the Mediterranean variant B(-) (563T) in 13 (29.5%), and the Betica-Selma A(-) (376G/968C) allelic variant in 6 (13.6%). The Santamaria A(-) variant (376G/542T) and A variant (376G) were observed in only one and two individuals, respectively. None of the expected variants was observed in 8 (18.2%) of the tested phenotypically G6PD-deficient men. CONCLUSION: This is the first published data on G6PD deficiency in Mauritanians. The prevalence of phenotypic G6PD deficiency was relatively high (11.3%). It was mostly associated with either African or Mediterranean variants, in agreement with diverse Arab and Black African origins of the Mauritanian population.
format Online
Article
Text
id pubmed-6746352
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67463522019-09-27 Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania Djigo, Oum kelthoum Mamadou Bollahi, Mohamed Abdallahi Hasni Ebou, Moina Ould Ahmedou Salem, Mohamed Salem Tahar, Rachida Bogreau, Hervé Basco, Leonardo Ould Mohamed Salem Boukhary, Ali PLoS One Research Article BACKGROUND: Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the use of primaquine has been limited in Africa. In the present study, G6PD deficiency was investigated in blood donors of various ethnic groups living in Nouakchott, a P. vivax endemic area in Mauritania. METHODOLOGY/PRINCIPAL FINDINGS: Venous blood samples from 443 healthy blood donors recruited at the National Transfusion Center in Nouakchott were screened for G6PD activity using the CareStart G6PD deficiency rapid diagnostic test. G6PD allelic variants were investigated using DiaPlexC G6PD genotyping kit that detects African (A(-)) and Mediterranean (B(-)) variants. Overall, 50 of 443 (11.3%) individuals (49 [11.8%] men and 1 [3.7%] woman) were phenotypically deficient. Amongst men, Black Africans had the highest prevalence of G6PD deficiency (15 of 100 [15%]) and White Moors the lowest (10 of 168, [5.9%]). The most commonly observed G6PD allelic variants among 44 tested G6PD-deficient men were the African variant A(-) (202A/376G) in 14 (31.8%), the Mediterranean variant B(-) (563T) in 13 (29.5%), and the Betica-Selma A(-) (376G/968C) allelic variant in 6 (13.6%). The Santamaria A(-) variant (376G/542T) and A variant (376G) were observed in only one and two individuals, respectively. None of the expected variants was observed in 8 (18.2%) of the tested phenotypically G6PD-deficient men. CONCLUSION: This is the first published data on G6PD deficiency in Mauritanians. The prevalence of phenotypic G6PD deficiency was relatively high (11.3%). It was mostly associated with either African or Mediterranean variants, in agreement with diverse Arab and Black African origins of the Mauritanian population. Public Library of Science 2019-09-16 /pmc/articles/PMC6746352/ /pubmed/31525211 http://dx.doi.org/10.1371/journal.pone.0220977 Text en © 2019 Djigo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Djigo, Oum kelthoum Mamadou
Bollahi, Mohamed Abdallahi
Hasni Ebou, Moina
Ould Ahmedou Salem, Mohamed Salem
Tahar, Rachida
Bogreau, Hervé
Basco, Leonardo
Ould Mohamed Salem Boukhary, Ali
Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
title Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
title_full Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
title_fullStr Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
title_full_unstemmed Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
title_short Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
title_sort assessment of glucose-6-phosphate dehydrogenase activity using carestart g6pd rapid diagnostic test and associated genetic variants in plasmodium vivax malaria endemic setting in mauritania
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746352/
https://www.ncbi.nlm.nih.gov/pubmed/31525211
http://dx.doi.org/10.1371/journal.pone.0220977
work_keys_str_mv AT djigooumkelthoummamadou assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania
AT bollahimohamedabdallahi assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania
AT hasnieboumoina assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania
AT ouldahmedousalemmohamedsalem assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania
AT taharrachida assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania
AT bogreauherve assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania
AT bascoleonardo assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania
AT ouldmohamedsalemboukharyali assessmentofglucose6phosphatedehydrogenaseactivityusingcarestartg6pdrapiddiagnostictestandassociatedgeneticvariantsinplasmodiumvivaxmalariaendemicsettinginmauritania